Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

S. J. Jacobus, S. V. Rajkumar, M. Weiss, A. K. Stewart, E. A. Stadtmauer, N. S. Callander, L. M. Dreosti, M. Q. Lacy, R. Fonseca

Research output: Contribution to journalLetterpeer-review

7 Scopus citations
Original languageEnglish (US)
Article numbere448
JournalBlood cancer journal
Issue number7
StatePublished - Jul 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this